Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial.
Talar-Wojnarowska R, Fabisiak A, Zatorski H, Płoszka K, Błaziak K, Fendler W, Rydzewska G, Małecka-Wojciesko E, Eder P. Talar-Wojnarowska R, et al. Among authors: zatorski h. Front Med (Lausanne). 2024 Sep 19;11:1458998. doi: 10.3389/fmed.2024.1458998. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39364021 Free PMC article.
Discharge protocol in acute pancreatitis: an international survey and cohort analysis.
Nagy R, Ocskay K, Sipos Z, Szentesi A, Vincze Á, Czakó L, Izbéki F, Shirinskaya NV, Poluektov VL, Zolotov AN, Zhu Y, Xia L, He W, Sutton R, Szatmary P, Mukherjee R, Burridge IS, Wauchope E, Francisco E, Aparicio D, Pinto B, Gomes A, Nunes V, Tantau VM, Sagau ED, Tantau AI, Suceveanu AI, Tocia C, Dumitru A, Pando E, Alberti P, Cirera A, Molero X, Lee HS, Jung MK, Kim EJ, Lee S, Rebollo MLR, Nistal RB, Santervas SI, Lesko D, Soltes M, Radonak J, Zatorski H, Małecka-Panas E, Fabisiak A, Yaroslav MS, Mykhailo VM, Olekcandr AT, Barauskas G, Simanaitis V, Ignatavicius P, Jinga M, Balaban VD, Patoni C, Gong L, Song K, Li Y, Gonçalves TC, Freitas M, Macedo V, Vornhuelz M, Klauss S, Beyer G, Koksal AS, Tozlu M, Eminler AT, Monclús NT, Comas EP, Oballe JAR, Nawacki Ł, Głuszek S, Rama-Fernández A, Galego M, de la Iglesia D, Aykut UE, Duman DG, Aslan R, Gherbon A, Deng L, Huang W, Xia Q, Poropat G, Radovan A, Vranić L, Ricci C, Ingaldi C, Casadei R, Negoi I, Ciubotaru C, Iordache FM, Constantinescu G, Sandru V, Altintas E, Balci HR, Constantino J, Aveiro D, Pereira J, Gunay S, Misirlioglu Sucan S, Dronov O, Kovalska I, Bush N, Rana SS, Chooklin S, Chuklin S, Saizu IA, Gheorghe C, Göltl… See abstract for full author list ➔ Nagy R, et al. Among authors: zatorski h. Sci Rep. 2023 Dec 13;13(1):22109. doi: 10.1038/s41598-023-48480-z. Sci Rep. 2023. PMID: 38092809 Free PMC article.
Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study.
Zagórowicz E, Cichoż-Lach H, Kopertowska-Majchrzak M, Eder P, Stawczyk-Eder K, Talar-Wojnarowska R, Zatorski H, Solarska-Półchłopek A, Filip R, Janiak M, Skrobot K, Kłopocka M, Liebert A, Kaczka A, Wojciechowski K, Drygała S, Michalak A. Zagórowicz E, et al. Among authors: zatorski h. Adv Clin Exp Med. 2024 Jan;33(1):69-77. doi: 10.17219/acem/162969. Adv Clin Exp Med. 2024. PMID: 37166016 Free article.
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
Eder P, Kłopocka M, Cichoż-Lach H, Talar-Wojnarowska R, Kopertowska-Majchrzak M, Michalak A, Filip R, Waszak K, Stawczyk-Eder K, Janiak M, Skrobot K, Liebert A, Zatorski H, Solarska-Półchłopek A, Krogulecki M, Pękała A, Poniewierka E, Smoła I, Kaczka A, Wojciechowski K, Drygała S, Zagórowicz E. Eder P, et al. Among authors: zatorski h. Therap Adv Gastroenterol. 2023 Feb 14;16:17562848231151295. doi: 10.1177/17562848231151295. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 36818601 Free PMC article.
Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
Kral J, Nakov R, Lanska V, Barberio B, Benech N, Blesl A, Brunet E, Capela T, Derikx L, Dragoni G, Eek A, Frias-Gomes C, Gîlcă-Blanariu GE, Gilroy L, Harvey P, Kagramanova A, Kani HT, Konikoff T, Lessing M, Madsen G, Maksimaityte V, Miasnikova M, Mikolasevic I, Milivojevic V, Noviello D, Oliinyk D, Patai A, Pisani A, Protopapas A, Rodríguez-Lago I, Schreiner P, Skuja V, Tran F, Truyens M, Włodarczyk M, Zatorski H, Verstockt B, Segal JP. Kral J, et al. Among authors: zatorski h. Dig Dis. 2023;41(3):387-395. doi: 10.1159/000528070. Epub 2022 Nov 21. Dig Dis. 2023. PMID: 36412565
Dietary Interventions in Inflammatory Bowel Disease.
Godala M, Gaszyńska E, Zatorski H, Małecka-Wojciesko E. Godala M, et al. Among authors: zatorski h. Nutrients. 2022 Oct 12;14(20):4261. doi: 10.3390/nu14204261. Nutrients. 2022. PMID: 36296945 Free PMC article. Review.
Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study.
Ocskay K, Juhász MF, Farkas N, Zádori N, Szakó L, Szakács Z, Szentesi A, Erőss B, Miklós E, Zemplényi A, Birkás B, Csathó Á, Hartung I, Nagy T, Czopf L, Izbéki F, Gajdán L, Papp M, Czakó L, Illés D, Marino MV, Mirabella A, Małecka-Panas E, Zatorski H, Susak Y, Opalchuk K, Capurso G, Apadula L, Gheorghe C, Saizu IA, Petersen OH, de-Madaria E, Rosendahl J, Párniczky A, Hegyi P; Hungarian Pancreatic Study Group. Ocskay K, et al. Among authors: zatorski h. BMJ Open. 2022 Jan 4;12(1):e050821. doi: 10.1136/bmjopen-2021-050821. BMJ Open. 2022. PMID: 34983758 Free PMC article.
39 results